Back to VA VANGUARD CAPITAL MANAGEMENT LLC
SYRE2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in Spyre Therapeutics, Inc
VANGUARD CAPITAL MANAGEMENT LLC holds 3.4M shares of SYRE (Spyre Therapeutics, Inc), worth $306.2M as of 2026-Q2. The position was increased (+12.8% shares). SYRE represents 0.0% of VANGUARD CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$306.2M
Current Shares
3.4M
Total Value Change
+$152M
Total Shares Change
+391,280
Quarter-by-Quarter History
Other major holders of SYRE: FMR LLC, BlackRock, Inc., RTW INVESTMENTS, LP